Risperidone Treatment in a Case of Tourette Syndrome with Factor V Leiden Heterozygous Mutation

Sari, Burcu AkinTaskintuna, NilgunYalcin, Ozhan2024-02-272024-02-2720141044-5463http://hdl.handle.net/11727/11664enginfo:eu-repo/semantics/closedAccessACTIVATED PROTEIN-CVENOUS THROMBOEMBOLISMPULMONARY-EMBOLISMRISKTHROMBOSISOLANZAPINERisperidone Treatment in a Case of Tourette Syndrome with Factor V Leiden Heterozygous Mutationletter2442352360003362307000112-s2.0-84901260184